AbbVie could be heading for its second acquisition in the space of a month, with reports emerging of late-stage negotiations with Gilgamesh Pharmaceuticals, a central nervous system (CNS) drug ...

AbbVie has agreed to pay $65 million on an option deal with start-up Gilgamesh Pharma, lining up rights to neuroplastogen compounds that can improve neuroplasticity - the ability of the brain to ...

Can you chip in? This year we’ve reached an extraordinary milestone: 1 trillion web pages preserved on the Wayback Machine. This makes us the largest public repository of internet history ever ...

Constance delivers a heartfelt and visually expressive adventure that blends Hollow Knight inspired movement with a unique brush based mechanic tied to emotion and creativity. Its narrative stands out ...

DiveWire guarantees visibility for your news announcements through instant distribution to BioPharma Dive’s audience and its 189,000 newsletter subscribers for 21 days.